Philippe B. Van Wilder

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Non-adherence and non-persistence with antiretroviral treatment in Belgium: A real-world evaluation using a pharmacy database, 2018-2021.

Non-adherence and non-persistence with antiretroviral treatment in Belgium: A real-world evaluation using a pharmacy database, 2018-2021.

Journal: Pharmacoepidemiology and drug safety
Published: July 26, 2023

The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis.

The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis.

Journal: Health research policy and systems
Published: January 10, 2023

Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study.

Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study.

Journal: BMC health services research
Published: June 15, 2022

Trends and regional variations in prescriptions dispensed to stimulate uterine contractions at the end of pregnancy in Belgium: A community-based study from 2003 to 2018.

Trends and regional variations in prescriptions dispensed to stimulate uterine contractions at the end of pregnancy in Belgium: A community-based study from 2003 to 2018.

Journal: Pharmacoepidemiology and drug safety
Published: April 04, 2022

Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care.

Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care.

Journal: Frontiers in pharmacology
Published: October 05, 2021

Informing Patients about Biosimilar Medicines: The Role of European Patient Associations.

Informing Patients about Biosimilar Medicines: The Role of European Patient Associations.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 31, 2020

Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis.

Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis.

Journal: Frontiers in pharmacology
Published: December 20, 2020

The impact of early phase price agreements on prices of orphan drugs.

The impact of early phase price agreements on prices of orphan drugs.

Journal: BMC health services research
Published: October 30, 2020

Cost-DALY comparison of hip replacement care in 12 Belgian hospitals.

Cost-DALY comparison of hip replacement care in 12 Belgian hospitals.

Journal: BMJ open quality
Published: October 29, 2020

Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): A health-economic assessment.

Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): A health-economic assessment.

Journal: PloS one
Published: August 12, 2020

Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective.

Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: January 31, 2020

Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium.

Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium.

Journal: European journal of clinical pharmacology
Published: November 13, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026